acorda therapeutics inc
(ACOR:Consolidated Issue Listed on NASDAQ Global Select )
Mark D. Noble Ph.D.
Member of Scientific Advisory Board, Acorda Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mark D. Noble Ph.D. is a Member of the Scientific Advisory Board of Acorda Therapeutics Inc. Dr. Noble is Professor of Genetics at the Center for Cancer Biology, University of Rochester Medical Center, Rochester, NY. Dr. Noble is a world leader in the areas of stem cell biology, central nervous system myelin repair, glial progenitor cells, and central nervous system regeneration. He is a recipient of the Jean Monnet Prize of the European Neurological Society, and serves ...
420 Saw Mill River RoadPhone: 914-347-4300
Ardsley, New York 10502
Board Members Memberships*There is no Board Members Memberships data available.
Franklin & Marshall College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|James E. Brown D.V.M.||Co-Founder, Chief Executive Officer, President and Director|
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Stephen R. Davis J.D.||Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President|
ACADIA Pharmaceuticals Inc.
|$245.6K||Compensation as of Fiscal Year 2014.|